4586 MEDRX
- 145
- +12+9.02%
MEDRX News
MEDRX: Extraordinary Report
Volume change rate ranking (10:00) ~ Almedio, Coconara, etc. are ranked
* In the volume change rate ranking, it is possible to know the interest of market participants, such as shopping trends, by comparing the average turnover for the last 5 days with the turnover on the day of distribution. ■Top Volume Change Rate [as of 5/17 10:32] (Last 5 Day Average Volume Comparison) Stock Code Stock Name Volume 5 Day Average Volume Volume Change Rate Stock Price Change Rate ＜7859＞ Almedio 5570100 195425.2 294.21% -0.0
Human T, Cygenia, etc.
＜2160＞Preparing to apply for a market classification change to the GNI Tokyo Stock Exchange Prime Market signed a business alliance (strategic partnership agreement) with Governance Partners, which handles the recruitment and management of investment funds Ortz, which handles P.A.I. (personal artificial intelligence) research and development, etc., established a joint venture with Governance Partners ＜3691＞Digital Plus earnings forecast revised, operating profit forecast 0.25 billion yen ←△ 102 million yen ＜4068＞Basis Downward revisions, current operating profit
Veritas in Silico, Minkab the Infonoid, etc.
＜130A＞Veritas Co., Ltd., Veritas in Silico Mitsubishi UFJ Capital Co., Ltd. (association name) Mitsubishi UFJ Life Science No. 1 Investment Limited Partnership Stock Ownership Ratio 8.14% → 7.90% Reporting Obligation Date 2024/05/07 ＜4419＞FINATEXT HOLDINGS CO., LTD. Ryota Hayashi Stock Ownership Ratio 38.55% → 37.62% Reporting Obligation Date 2024/05/14 ＜4436＞ Shares
MonoAI, Hope, etc. [Emerging Markets Press Release]
＜3727＞APLIX earnings forecast revisions, current fiscal year business profit forecast 219 million yen ← 264 million yen ＜4262＞acquisition of shares in Doors, which handles the operation of the Nifty Life exterior wall painting specialty site “Exterior Wall Painting Window,” and making it a subsidiary ＜4563＞Anges 1st Unsecured Convertible Bonds Type Stock Acquisition Rights Corporate Bonds (with conversion price correction clauses) number of shares issued since the 13th, 736,614 shares ＜4579＞LaQuoria Drug Discovery Exterior Wall Remodeling Support Agreement Businesses Consolidated subsidiary that handles it
Medrex, Blue Innovations, etc.
＜153A＞Kaulis Co., Ltd. Shimazu Atsuyoshi Stock Ownership Ratio 59.63% → 55.71% Reporting Obligation Date 2024/04/25 ＜3133＞Kaiho Co., Ltd. Yamada Toru Stock Ownership Ratio 12.99% → 14.18% Reporting Obligation Date 2024/04/26 ＜3976＞Shannon Co., Ltd. Wiz Partners Co., Ltd. Stock Ownership Ratio 57.31% → 58.54% Reporting Obligation Date 2024/05/0
Classicom, Confidence I, etc.
＜2351＞ASJ upward revision, previous fiscal year operating profit forecast 102 million yen ← 80 billion yen ＜3286＞Trust HD shareholder benefit plan newly established ＜3625＞ tech firm earnings forecast revision, current fiscal year sales forecast 5.00 billion yen ← 6.00 billion yen ＜3917＞formulating a medium-term management plan involving iRidge from the fiscal year ending 25/3 to the fiscal year ending 27/3 ＜4165＞ Played revised upward, sales forecast for the current fiscal year ending 10.809 billion yen ← 10.666 billion yen <43
MEDRX: Confirmation
MEDRX: Quarterly Report - 23rd Quarter 1 (2024/01/01 - 2024/03/31)
MEDRX: Consolidated Financial Results for the 1st Quarter Ending 2024/12 [Japanese GAAP] (Consolidated)
MEDRX: Notice regarding revisions to earnings forecasts
Kids Smile, Media Research Institute, etc.
＜3970＞Innovation downward revision, operating profit forecast 399 million yen ← 850 million yen ＜4477＞BASE earnings forecast revision, current fiscal year ordinary profit forecast 0.03 billion yen ←△2.04 to △ 0.03 billion yen ＜4586＞patent assessment relating to Medlec MRX-5LBT (Japan) ＜5884＞Kuradashi downward revision, current fiscal year operating profit forecast 0.24 billion yen ← 0.45 billion yen ＜7063＞issuance of new shares through birdman third party allotment (1.4 million shares) Issuance of stock acquisition rights (subdued)
Daiwa House, Meiji HD, Shiseido, Sumitomo Electric (10th) (1301-5998)
*The above calendar is just a schedule and is subject to change due to company circumstances. ---------------------------------------5/10 (Fri) ＜1301＞Kyokuyo ＜1379＞Hokuto ＜1414＞Show Bond ＜1420＞Sanyo H＜1429＞Japan Aqua ＜1431＞Ribwork＜1435＞Robot Home ＜1438＞Gifu Landscaping＜1
Medlec, Note, etc. [Emerging Markets Press Release]
＜3645＞Medical Net Shareholder Benefit System＜4586＞Medlec 28th Stock Acquisition Rights (with exercise price amendment clause) number of shares issued from the 7th, 875,000 shares ＜4582＞ Symbio Pharma downward revisions, operating loss forecast for the current fiscal year △ 3.702 billion yen ← △ 2,837 billion yen ＜4978＞Reprocel downward revision, previous fiscal year operating loss forecast △ 409 million yen ←△ 110 million yen ＜5243＞net subsidiary established and new business started < 7372 > below décolletage HD
Amagasa, core concept technology, etc.
＜177A＞Cojin Bio Co., Ltd. Oriental Yeast Industrial Co., Ltd. Stock Ownership Ratio -% → 5.38% Reporting Obligation Date 2024/04/25 ＜177A＞Cojin Bio Co., Ltd. Nakamura Takato Stock Ownership Ratio -% → 53.86% Reporting Obligation Date 2024/04/25 ＜3070＞Amagasa Co., Ltd. Milestone Capital Management Co., Ltd. Stock Ownership Ratio 13.85% → 8.12%
Jade Group, Medrex, etc
＜2934＞J-Frontier Co., Ltd. Nakamura Atsuhiro Stock Ownership Ratio 68.87% → 65.59% Reporting Obligation Date 2024/04/25 ＜3133＞Kaiho Co., Ltd. Yamada Toru Stock Ownership Ratio 12.99% → 14.18% Reporting Obligation Date 2024/04/26 ＜3237＞Intrans Co., Ltd. Intrans LLC Inbound Investment Stock Ownership Ratio 43.50% → 43.50% Reporting Obligation
Media Research Institute, 3D Matrix, etc.
＜4564＞Number of shares issued from mass exercise of the 36th OTS Stock Acquisition Rights (with exercise price amendment clause), 6 million shares ＜4586＞number of shares issued from mass exercise 1 of the 28th Medlec Stock Acquisition Rights (with exercise price correction clauses), 600,000 shares ＜5256＞FusicAI training systems sold ＜7777＞3D Matrix TDM-623 Apply for approval<9242
Unite & Grow, Medrex, etc.
＜4486＞Unite & Grow Co., Ltd. Sumitomo Mitsui DS Asset Management Co., Ltd. Stock Ownership Ratio -% → 5.03% Reporting Obligation Date 2024/03/15 ＜4586＞Medrex Evo Fund Co., Ltd. Stock Ownership Ratio 16.22% → 16.38% Reporting Obligation Occurrence Date 2024/04/17 ＜4882＞Perseus Proteomics Co., Ltd. Barclays Bank PLC (
Linkers, etc. [strange brands seen from changes in turnover]
Stock closing price turnover compared to the previous day*＜5131＞Linkers 220 50 13582500*＜6467＞Nichidai 385 25 1128800*＜4586＞Medlec 118 2 5918200*＜1815＞Tekken 2927 209 438000*＜6858＞Ono Sokki 703 14 569500*＜7215＞Faltech
Brands that moved the day before part 2 PLANT, Sumiseki HD, Regil, etc.
<コード>Stock name closing price on the 24th ⇒ revised downward to the final major deficit due to Ahresty ＜5852＞ 647 -129 impairment recording compared to the previous day. Disgusted with potential dilution due to the issuance of Resonac ＜4004＞ 3390 -321CB. Profitable sales from fund shifts in the high price range of Hokkaido Electric Power ＜9509＞ 1155.5 -82.5. Orbic ＜4684＞ The rate of increase in sales for the fiscal year ending 20035 -16351-3 fell to the 1-digit range. Strike ＜6196＞ 4445 -365
Analysis
Price Target
No Data
